Two-year results of the ASCEND trial of olipudase alfa adults with chronic acid sphingomyelinase deficiency show parallel improvements in former placebo patients and further improvement in continuing olipudase alfa patients
Yükleniyor...
Tarih
Dergi Başlığı
Dergi ISSN
Cilt Başlığı
Yayıncı
Academic Press Inc Elsevier Science
Erişim Hakkı
info:eu-repo/semantics/closedAccess
Özet
[No abstract available]
Açıklama
18th Annual WORLD Symposium -- FEB 07-11, 2022 -- San Diego, CA
Anahtar Kelimeler
Kaynak
Molecular Genetics and Metabolism
WoS Q Değeri
Scopus Q Değeri
Cilt
135
Sayı
2
